Author Topic: DVA DaVita HealthCare Partners  (Read 149262 times)

elevensecsrt4

  • Jr. Member
  • **
  • Posts: 53
Re: DVA DaVita HealthCare Partners
« Reply #30 on: September 07, 2014, 10:53:43 AM »
For some reason I am having a hard time understanding why davita would continue to accept (allow) medicare paid patients who make up 90% of the dialysis market where they lose money on every treatment.  I find it hard to believe private insurance companies are basically paying for everyone to be on dialysis ( or all of the profits davita generates) That has got to be a rather large difference in payment.


Do you all feel the goal is to expand efficiently to lower overall operating costs to make marginal profit (very tiny) on all govt paid patients? I am in awe the company has a profit at all with just 10% of its patients being profitable patients.

HealthCare partners acquisition was definitely aimed at getting more private insurance payers connected with Davita ( in their system), although patients not on dialysis yet but with kidney issues and for improving overall well being.

Is it just me or did anyone notice Ted W. buys were basically after or around the time the "merger" or Aquisistion of HC partners was announced?

He obviously knows the company well and has been invested for years but his brk $ buys happened shortly after the M&A and could just be a coincidence.

I guess I'm just making a general comment that private insurance payers paying for services from DVA should be welcomed with both arms.

Sorry for the newbie discussion points.  I'm in the early stages of understanding the business.

Love this site by the way! ;D



ItsAValueTrap

  • Hero Member
  • *****
  • Posts: 1945
    • Blog
Re: DVA DaVita HealthCare Partners
« Reply #31 on: September 07, 2014, 11:22:40 AM »
Quote
That has got to be a rather large difference in payment.
They more or less are getting gouged due to the limited supply of dialysis centers and doctors.  Sometimes the doctors receive financial compensation from dialysis centers so they may be participating in the gouging.  There are laws against this; DaVita had to pay a settlement because it kind of broke these laws.

From a patient's perspective, you want to go to a dialysis clinic that is close to you.  Otherwise you are spending a huge chunk of your time each week traveling to the dialysis clinic.  Because of this, the clinics kind of have pricing power.  In some areas it is close to a monopoly.  In some areas, DaVita will own most of the dialysis clinics so it becomes more of a monopoly.
"It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price. " -Buffett

my blog

compounding

  • Full Member
  • ***
  • Posts: 143
Re: DVA DaVita HealthCare Partners
« Reply #32 on: October 12, 2014, 02:43:59 AM »
@JohanHjortsson

ItsAValueTrap

  • Hero Member
  • *****
  • Posts: 1945
    • Blog
Re: DVA DaVita HealthCare Partners
« Reply #33 on: October 12, 2014, 09:29:03 AM »
Interesting, via @PlanMaestro On Twitter:

http://news.harvard.edu/gazette/story/2014/10/giant-leap-against-diabetes/

Stem cell research seems to be very slow.  We haven't done much beyond skin.

HART (which pays for stock promotion) is researching stem cells for the human esophagus.  They're having problems with the technology.  More complex body parts seem to be far, far away.
"It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price. " -Buffett

my blog

fareastwarriors

  • Hero Member
  • *****
  • Posts: 3462
Re: DVA DaVita HealthCare Partners
« Reply #34 on: October 23, 2014, 01:19:04 PM »

Fat Pitch

  • Full Member
  • ***
  • Posts: 224
  • Crowd Home Plate and Wait for the Right Pitch
    • FatPitchInvestments.com
Re: DVA DaVita HealthCare Partners
« Reply #35 on: October 23, 2014, 04:38:07 PM »
Where Seeking Out Risk Adjusted Return is our Passion!

compounding

  • Full Member
  • ***
  • Posts: 143
Re: DVA DaVita HealthCare Partners
« Reply #36 on: January 26, 2015, 04:21:33 AM »
DaVita Ranks First in Clinical Outcomes According to Government Reports

http://finance.yahoo.com/news/davita-ranks-first-clinical-outcomes-110900312.html
@JohanHjortsson

ni-co

  • Hero Member
  • *****
  • Posts: 978
Re: DVA DaVita HealthCare Partners
« Reply #37 on: February 13, 2015, 08:18:52 AM »
If you are in the market for some DVA shares, today'd be the day to buy them.

Quote
HCP, $33 million NOI, right in the middle of the guidance for the quarter. But let's hit the bad news right up front, and that is that CMS may make multiple changes to Medicare Advantage reimbursement. And in aggregate, this could mean that HealthCare Partners 2016 NOI could be below and even well below 2015, so unambiguous, potential bad news on that side.

We incorrectly handicapped the Medicare Advantage reimbursement cuts last year, and I apologize that -- for that. I got it wrong. This actually is becoming a strategic issue for Medicare Advantage in our minds that it is crucial for CMS to protect the incentive to innovate to create health where now there is sickness and reduce risk where it is high for these patients, and we hope they realize that in their near-term decision-making.

http://seekingalpha.com/article/2914006-davita-healthcare-partners-dva-q4-2014-results-earnings-call-transcript

LC

  • Hero Member
  • *****
  • Posts: 2585
Re: DVA DaVita HealthCare Partners
« Reply #38 on: February 13, 2015, 09:35:39 AM »
I exited my position yesterday...basically pure luck saved me 5pct. I read Glenn's post on DVA and just said I don't want to deal with companies doing potentially unethical stuff. It's hard enough to get a handle on normal business factors...throw in the unethical/illegal stuff and it's just too much brain damage.
"Lethargy bordering on sloth remains the cornerstone of our investment style."
----------------------------------------------------------------------------------------
brk.b | cash

SwedishValue

  • Jr. Member
  • **
  • Posts: 84
Re: DVA DaVita HealthCare Partners
« Reply #39 on: February 13, 2015, 10:48:08 AM »
They are cost leaders at providing a life sustaining service, and they provide it with the best clinical results in adjusted groups. I'm not denying the charges that have been brought to DVA before, but I would strongly disagree with it being an unethical business. (I can appeal to authority and hint at Ted Weschler's opinion as well).

I don't see the big news dropping the share down today. Thiry and his colleagues have said repeatedly that Medicare Advantage and cuts in reimbursement rates will pose significant challenges for the coming years, a statement that now was re-iterated for probably more than the 10th consecutive conference call. DVA has been very good at coping with changes in reimbursement rates historically, and the underlying growth of the most important business segment (dialysis) is organically very high (unfortunately, I really wish this would stop but it's not going to).